Please login to the form below

Not currently logged in
Email:
Password:

pain treatment

This page shows the latest pain treatment news and features for those working in and with pharma, biotech and healthcare.

Daiichi Sankyo starts mirogabalin trial in spinal injury pain

Daiichi Sankyo starts mirogabalin trial in spinal injury pain

The non-opioid painkiller was registered in Japan under the Tarlige brand name as a treatment for diabetic peripheral neuropathic pain (PNP) and postherpetic neuralgia (PHN) in January, and is a ... Around three-quarters of spinal cord injury patients

Latest news

  • Brexit contributes to surge in generic drug prices Brexit contributes to surge in generic drug prices

    He says some medicines would be “particularly vulnerable" - highlighting a current shortage of pain and opioid addiction treatment Buprenorphine and antipsychotic Risperidone, arising in particular because there are no simple alternatives

  • The Final Frontier The Final Frontier

    Maybe. The Canadian Pain Society recently moved cannabinoid therapy up from a fourth-line treatment option to a third-line treatment option for neuropathic pain. ... They sent questionnaires to households asking about self-reported pain frequency,

  • FDA awards another non-opioid pain drug breakthrough status FDA awards another non-opioid pain drug breakthrough status

    Frank Bellizzi, CEO of Concentric Analgesics said the BTD confirmed the strong early data for the treatment, which is designed to treat pain and eliminate the need for opioids in the ... The announcement follows a BTD in June for Heron Therapeutics and

  • Daily Brief: another departure at Gilead, veteran researcher to head up Karuna Daily Brief: another departure at Gilead, veteran researcher to head up Karuna

    Boston, Mass-based Karuna Pharmaceuticals is focused on targeting muscarinic cholinergic receptors for the treatment of neuropsychiatric disorders marked by psychosis and cognitive impairment. ... We are also excited by recent preclinical work suggesting

  • First migraine prevention drug to hit European market First migraine prevention drug to hit European market

    The European Commission (EC) approved the novel treatment yesterday after it received a positive recommendation from the European Medicine Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) last ... The treatment seems to be off to a

More from news
Approximately 2 fully matching, plus 100 partially matching documents found.

Latest Intelligence

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    One potential major product launch for 2019 will be novel pain drug tanezumab. ... These new products will help offset the patent expiry of one of Pfizer’s biggest products, pain treatment Lyrica, which will see generics arrive at the end of December.

  • Mobile health and patient outcomes Mobile health and patient outcomes

    Putting the humanity back into patient care. Healthcare professionals, scientists and pharmaceutical companies’ understanding of the daily impact of disease and treatment on a person’s life are not always as ... In a recent study in rheumatoid

  • Deal Watch - May 2017 Deal Watch - May 2017

    its bupivacaine collagen implant for treatment of post-operative pain. ... 1, 050. Akebia (US). Otsuka (JP). Licence expansion selected countries. Vadadustat in phase 3 for treatment of anaemia.

  • Deal Watch February 2017 Deal Watch February 2017

    Cynosure's portfolio of more than 20 products covers areas such as non-invasive body contouring (including SculpSure, an FDA approved laser treatment for body contouring), hair removal, skin revitalisation and ... Combined the five products cover eight

  • Oral biologics delivery still elusive Oral biologics delivery still elusive

    Cara Therapeutics has a chronic pain treatment based on a peptide that is rendered orally bioavailable using Enteris Biopharma's Peptelligence platform, which combines a permeation enhancer and a calcium chelator ... As the intestines don't have sharp

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • THE OTHER SIDE OF … GOUT

    Doctors’ goals, on the other hand, seem to be lower. “Keep doing what you are doing”, they tell Jan when she complains about her pain, continuing to prescribe the same treatment. ... work to shift beliefs and increase motivation to improve care and

  • Virtual reality—a change for the better in medical education

    VR’s usefulness in cancer treatment doesn’t just extend into pain management. ... The impact of virtual reality distraction on pain and anxiety during dental treatment in 4–6 year-old children: a randomized controlled clinical trial.

  • 6 things that doctors want

    Doctors want a stronger collaboration with industry with the objective of raising the quality of patient care and improving treatment outcomes.What this means is that the barriers to healthcare professional ... adherence conditions like hypertension–

  • Research Partnership

    Breaking Down the Barriers to Effective Treatment of Hepatitis C in Latin America. ... Barriers to Biologic Treatment - Is Injecting Such a Pain?.

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics